
AP5 sodium is a мощный, orall active, and селективный GPR40 рецептор агонист with a positive allosteric modulation of endogenous лиганд (AgoPAM). AP5 sodium demonstrates rat and human inositol monophosphate (IP1) EC50 values of 0.49 nM and 0.8 nM against the GPR40 рецептор, respectively. AP5 sodium has the potential for type II diabetes research.
AP5 sodium is a potent, orall active, and selective GPR40 receptor agonist with a positive allosteric modulation of endogenous ligand (AgoPAM). AP5 sodium demonstrates rat and human inositol monophosphate (IP1) EC50 values of 0.49 nM and 0.8 nM against the GPR40 receptor, respectively. AP5 sodium has the potential for type II diabetes research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.